Komori
Jmdc (4483) · InitiativeDropped

Development, sales and operational testing of systems for dispensing pharmacies

First written in FY2020-Q3. 10 of 16 entries say "Restated". Latest entry: FY2025.

16entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021-Q1 – FY2021-Q3RestatedFY2022-Q2 – FY2023-Q3RestatedFY2024-Q2 – FY20252020: 320202021: 320212022: 420222023: 420232024: 120242025: 12025
Same theme, other companies
Development and sale of business systems for dispensing pharmacies and exit from the businessA theme 2 companies write about · 1 as a headwind · 1 as a tailwind

0 other companies' latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2025DroppedAnnual report

    「As stated in the “Notice Regarding Changes in Subsidiaries, Etc. (Share Transfer) and Changes to Reportable Segments” published on 20 February 2025, we transferred all shares of Noah Medical System Co., Ltd. (hereinafter, “Noah Medical”), formerly our consolidated subsidiary, to Kakehashi Co., Ltd. Accordingly, in the current consolidated fiscal year, the business operated by Noah Medical relating to support for dispensing pharmacies was classified as a discontinued operation.」

    The transfer of all shares of Noah Medical was completed, and the pharmacy support business was classified as a discontinued operation. The description treating the development and sale of systems for dispensing pharmacies as a continuing operation has been removed.
  2. FY2024-Q3RestatedAnnual report

    「Through this transfer, we will further accelerate the initiatives undertaken by both companies, provide even higher-quality services, and increase our market share by creating a new wave in the pharmacy market.」

    Following the transfer of Unike Software Research and related businesses, reiterates the direction of accelerating initiatives with EM SYSTEMS to improve service quality and market share in the pharmacy market.
  3. FY2024-Q2RestatedAnnual report

    「Through this transfer, we will further accelerate the initiatives undertaken by both companies, provide even higher-quality services, and increase our market share by creating a new wave in the pharmacy market.」

    Following the transfer of Unike Software Research and related businesses, reiterates the direction of accelerating initiatives with EM SYSTEMS to improve service quality and market share in the pharmacy market.
  4. FY2024-Q1ReframedAnnual report

    「The pharmacy support segment develops and sells systems, including prescription-receipt computers and electronic medication-record systems, for health insurance pharmacies.」

    Following the transfer of Unike Software Research and related businesses, the company is focusing on the development and sale of systems for health insurance pharmacies, without including the previously described operation of company-owned dispensing pharmacies and operational testing.
  5. FY2023ReframedAnnual report

    「At a meeting of the Board of Directors held on 26 June 2023, we resolved to transfer all shares of our consolidated subsidiary Unike Software Research Co., Ltd. and its management-purpose company to EM SYSTEMS CO., LTD., and transferred the shares on 30 June 2023.」

    Regarding the system business for dispensing pharmacies, the positioning has changed following the transfer of Unike Software Research to EM SYSTEMS. The direction is to combine the experience represented by the P-CUBE brand with EM SYSTEMS’ expertise and development capabilities in pharmacy digital transformation to improve service quality and market share.
  6. FY2023-Q3RestatedAnnual report

    「The pharmacy support segment develops and sells systems such as claims processing systems and electronic medication history systems to health insurance pharmacies, while also operating dispensing pharmacies itself, where it conducts operational testing of its proprietary systems.」

    The company reiterates its development and sale of business systems for dispensing pharmacies and operational testing using its own pharmacies.
  7. FY2023-Q2RestatedAnnual report

    「The pharmacy support segment develops and sells systems such as claims processing systems and electronic medication history systems to health insurance pharmacies, while also operating dispensing pharmacies itself, where it conducts operational testing of its proprietary systems.」

    Reiterates the development and sale of systems for dispensing pharmacies and operational testing using company-operated pharmacies.
  8. FY2023-Q1RestatedAnnual report

    「The pharmacy support segment develops and sells systems such as claims processing systems and electronic medication history systems to health insurance pharmacies, while also operating dispensing pharmacies itself, where it conducts operational testing of its proprietary systems.」

    The company reiterates its development and sale of business systems for dispensing pharmacies and operational testing using its own pharmacies.
  9. FY2022RestatedAnnual report

    「In the pharmacy support business, we provide business systems for dispensing pharmacies, including prescription-receipt computers and electronic medication records, and aim to build a “smart pharmacy” environment in which pharmacists prescribing medications can provide patients with the necessary information appropriately.」

    Reiterates the integrated initiatives of providing systems for dispensing pharmacies, conducting operational testing at company-operated pharmacies, and building smart pharmacies.
  10. FY2022-Q3RestatedAnnual report

    「The pharmacy support segment develops and sells systems such as claims processing systems and electronic medication history systems to health insurance pharmacies, while also operating dispensing pharmacies itself, where it conducts operational testing of its proprietary systems.」

    Reiterates the development and sale of systems for dispensing pharmacies and operational testing using pharmacies operated by the company.
  11. FY2022-Q2RestatedAnnual report

    「The pharmacy support segment develops and sells systems such as claims processing systems and electronic medication history systems to health insurance pharmacies, while also operating dispensing pharmacies itself, where it conducts operational testing of its proprietary systems.」

    The company reiterates its development and sale of business systems for dispensing pharmacies and operational testing using its own pharmacies.
  12. FY2022-Q1AdvancedAnnual report

    「The company continues to be affected by lower sales at its own dispensing pharmacies, due to reduced pharmacy usage resulting from patients avoiding visits to medical institutions amid the spread of COVID-19, as well as by customers' restraint on investment. However, revenue increased year on year following the launch of sales of the next-generation integrated electronic medication history and claims processing system P-CUBEn and the addition of another industry participant to the group.」

    Reports the concrete development of the launch of sales of the next-generation integrated electronic medication-record and prescription-receipt computer system, “P-CUBEn.”
  13. FY2021-Q3RestatedAnnual report

    「The pharmacy support segment develops and sells systems such as claims processing systems and electronic medication history systems to health insurance pharmacies, while also operating dispensing pharmacies itself, where it conducts operational testing of its proprietary systems.」

    The company reiterates its development and sale of business systems for dispensing pharmacies and operational testing using its own pharmacies.
  14. FY2021-Q1RestatedAnnual report

    「In addition to developing and selling systems such as claims processing systems and electronic medication history systems to health insurance pharmacies, the company operates dispensing pharmacies itself, where it conducts operational testing of its proprietary systems.」

    The company reiterates its development and sale of business systems for dispensing pharmacies and operational testing using its own pharmacies.
  15. FY2020AdvancedAnnual report

    「The company is currently developing a new cloud-based product consisting of a business system for dispensing pharmacies. In addition, because dispensing pharmacies using the business system accumulate claims data and medication history data daily, the company will, after following appropriate procedures, work to build a higher-value-added database and develop solutions for dispensing pharmacies by combining those data with other databases held by the group.」

    The company provides details of its plans to develop a new cloud-based product and combine pharmacy data with other databases.
  16. FY2020-Q3First statedAnnual report

    「In addition to developing and selling systems such as claims processing systems and electronic medication history systems to health insurance pharmacies, the pharmacy support business operates dispensing pharmacies itself, where it conducts operational testing of its proprietary systems.」

    In addition to providing business systems for health insurance pharmacies, the company identifies operational testing at its own pharmacies as a means of testing the systems.
Moved together

"Expansion of Contracted Radiologists and Contracted Medical Institutions" moved the same way as this thread, in the same document, in 2 of its 16 moves.

222★123
  1. ★This thread
  2. 1Expansion of Contracted Radiologists and Contracted Medical Institutions2×
  3. 2Revenue and earnings growth underpinned by three businesses2×
  4. 3Share Dilution from the Exercise of Share Acquisition Rights2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Jmdc's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Development, sales and operational testing of systems for dispensing pharmacies | JMDC Inc. (4483) | Komori